In order to determine the therapeutic potency of DC8E8 antibody in vivo, we utilized transgenic mice expressing pathogenic non-mutated human truncated tau (151–391/3R) with the ability to induce neurofibrillary pathology similar to human NFTs located predominantly in the brainstem [73, 107]. Here, MAPT is linked to Neurofibrillary tangles.